This elevated type-2 inflammatory response was also evident in BAL cellular influx, with numeric and proportional increase in BAL eosinophils, CD4+ and CD8+ T cells during patent infection (Fig. 4C), patterns seen to a lesser extent in pre-patent infection (Fig. 3C). The gene discussed is CD8A; the disease is infection.